加载中
NASDAQHealthcareBiotechnology
最新数据
US$0.8896
−US$0.1304 · -12.78%
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
收盘时
US$0.8896
−US$0.1304 · -12.78%
盘中时间采用ET。市场数据可能有所延迟。
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
日内区间
当前US$0.8896
52周区间
当前US$0.8896
盘中时间采用ET。市场数据可能有所延迟。
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
日内区间
当前US$0.8896
52周区间
当前US$0.8896
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 研究与开发 | 293万 USD | 820.37万 USD | 407万 USD | 565.1万 USD | 345.93万 USD |
| 销售、一般及管理费用 | 484.36万 USD | 430.96万 USD | 397.2万 USD | 402.34万 USD | 439.75万 USD |
| 营业费用 | 777.36万 USD | 1251.32万 USD | 804.2万 USD | 967.45万 USD | 785.69万 USD |
| 利息收入 | 21.5万 USD | 22.58万 USD | 24.72万 USD | 6.36万 USD | 45.61 USD |
| 利息支出 | — | — | — | — | 4.56万 USD |
| 折旧和摊销 | — | — | 804.19万 USD | — | — |
| 营业利润 | −777.36万 USD | −1251.32万 USD | −804.2万 USD | −967.45万 USD | −785.69万 USD |
| 净利润 | −755.86万 USD | −1228.75万 USD | −779.5万 USD | −961.09万 USD | −790.25万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
